Progressive pulmonary fibrosis: an expert group consensus statement.
Rajan SK, Cottin V, Dhar R, Danoff S, Flaherty KR, Brown KK, Mohan A, Renzoni E, Mohan M, Udwadia Z, Shenoy P, Currow D, Devraj A, Jankharia B, Kulshrestha R, Jones S, Ravaglia C, Quadrelli S, Iyer R, Dhooria S, Kolb M, Wells AU.
Eur Respir J. 2023 Mar 30;61(3):2103187. doi: 10.1183/13993003.03187-2021. Print 2023 Mar.
Update on cryptogenic organizing pneumonia.
Radzikowska E, Fijolek J.
Front Med (Lausanne). 2023 Apr 20;10:1146782. doi: 10.3389/fmed.2023.1146782. eCollection 2023.
Pulmonary Complications of Systemic Lupus Erythematosus.
Hannah JR, D'Cruz DP.
Semin Respir Crit Care Med. 2019 Apr;40(2):227-234. doi: 10.1055/s-0039-1685537. Epub 2019 May 28.
Drug induced pulmonary parenchymal disease.
Prasad R, Gupta P, Singh A, Goel N.
Drug Discov Ther. 2014 Dec;8(6):232-7. doi: 10.5582/ddt.2014.01046.
The Evolving Profile of Idiosyncratic Drug-Induced Liver Injury.
Fontana RJ, Bjornsson ES, Reddy R, Andrade RJ.
Clin Gastroenterol Hepatol. 2023 Jul;21(8):2088-2099. doi: 10.1016/j.cgh.2022.12.040. Epub 2023 Mar 1.
Drug-induced pulmonary vascular disease--mechanisms and clinical patterns.
Kumar K, Holden WE.
West J Med. 1986 Sep;145(3):343-9.
Eosinophilic Pneumonias.
Allen J, Wert M.
J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1455-1461. doi: 10.1016/j.jaip.2018.03.011. Epub 2018 May 4.
Drug-induced pulmonary edema and acute respiratory distress syndrome.
Lee-Chiong T Jr, Matthay RA.
Clin Chest Med. 2004 Mar;25(1):95-104. doi: 10.1016/S0272-5231(03)00128-X.
Recognition of Sympathetic Crashing Acute Pulmonary Edema (SCAPE) and use of high-dose nitroglycerin infusion.
Paone S, Clarkson L, Sin B, Punnapuzha S.
Am J Emerg Med. 2018 Aug;36(8):1526.e5-1526.e7. doi: 10.1016/j.ajem.2018.05.013. Epub 2018 May 10.
Roflumilast.
[No authors listed]
2018 Jun 4. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
